Moneycontrol PRO

FiDEX 2026

FiDEX 2026

SHOW NAMES

Trending Topics

business

Prefer Sun Pharmaceutical, Lupin: Jitendra Sriram

Jitendra Sriram, MD & Head of Research of HSBC India is of the view that one may prefer Sun Pharmaceutical and Lupin from the pharma space.

first published: Sep 18, 2013 11:23 am

LATEST VIDEOS

A collection of the most-viewed Moneycontrol videos.

U.S.-Iran Conflict Will Have Huge Impact On Global Markets, Businesses, Supply Chain: Nalin Mehta
Rising Bharat Summit 2026 | “Satellite Can Go Where Others Can’t” – Jyotiraditya Scindia
Rising Bharat Summit 2026 | “AI Creates More Opportunities” – Jyotiraditya Scindia
Rising Bharat Summit 2026 | Piyush Goyal Answers the Big India–US Trade Deal Question

Watch and Follow our leading shows

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347